An updated mandate from the Food and Drug Administration compels U.S.
The new regulation demands more communication from screening facilities across 12 states, including Alaska, Wyoming, Idaho and Montana.
A vaccine designed to battle breast cancer is moving to a randomized, Phase II clinica
Study findings suggest that a vaccine could be used to prevent or treat a particularly aggressive form of breast cancer.
The study's lead author expresses surprise that patients still under the care of cancer specialists would forgo these diagnostic exams.
Radiologists feel pressure to use and promote technology still unproven in population-level studies, editorial says.
Variants in the ATM, CHEK2 and PALB2 genes are collectively as prevalent as the much-reported BRCA1/2 gene mutations.
The breast cancer vaccine researcher is an inaugural member of the advisory group, which spans medicine and journalism.
A study points up racial disparities in biopsies and detected breast cancers during a 2020 span when routine screenings were greatly slowed.
The technology’s potential benefits to detect breast cancer earlier are not equally shared across sub-populations of women, researchers find.